These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 30291344)

  • 21. Lymphocyte activation gene (LAG)-3 is a potential immunotherapeutic target for microsatellite stable, programmed death-ligand 1 (PD-L1)-positive endometrioid endometrial cancer.
    Hong JH; Cho HW; Ouh YT; Lee JK; Chun Y
    J Gynecol Oncol; 2023 Mar; 34(2):e18. PubMed ID: 36509464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of Immunological Characteristics and Genomic Alterations in HPV-Positive Oropharyngeal Squamous Cell Carcinoma Based on PD-L1 Expression.
    Xu SM; Shi CJ; Xia RH; Wang LZ; Tian Z; Ye WM; Liu L; Liu SL; Zhang CY; Hu YH; Zhou R; Han Y; Wang Y; Zhang ZY; Li J
    Front Immunol; 2021; 12():798424. PubMed ID: 35145511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T-lymphocyte profiles differ between keratoacanthomas and invasive squamous cell carcinomas of the human skin.
    Bauer C; Abdul Pari AA; Umansky V; Utikal J; Boukamp P; Augustin HG; Goerdt S; Géraud C; Felcht M
    Cancer Immunol Immunother; 2018 Jul; 67(7):1147-1157. PubMed ID: 29799076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1.
    Howitt BE; Shukla SA; Sholl LM; Ritterhouse LL; Watkins JC; Rodig S; Stover E; Strickland KC; D'Andrea AD; Wu CJ; Matulonis UA; Konstantinopoulos PA
    JAMA Oncol; 2015 Dec; 1(9):1319-23. PubMed ID: 26181000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T cell-inflamed phenotype and increased Foxp3 expression in infiltrating T-cells of mismatch-repair deficient endometrial cancers.
    Asaka S; Yen TT; Wang TL; Shih IM; Gaillard S
    Mod Pathol; 2019 Apr; 32(4):576-584. PubMed ID: 30401949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PD-L1 expression combined with microsatellite instability/CD8+ tumor infiltrating lymphocytes as a useful prognostic biomarker in gastric cancer.
    Morihiro T; Kuroda S; Kanaya N; Kakiuchi Y; Kubota T; Aoyama K; Tanaka T; Kikuchi S; Nagasaka T; Nishizaki M; Kagawa S; Tazawa H; Fujiwara T
    Sci Rep; 2019 Mar; 9(1):4633. PubMed ID: 30874607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MHC class I loss in endometrial carcinoma: a potential resistance mechanism to immune checkpoint inhibition.
    Friedman LA; Bullock TN; Sloan EA; Ring KL; Mills AM
    Mod Pathol; 2021 Mar; 34(3):627-636. PubMed ID: 33011747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic implication of programmed cell death 1 protein and its ligand expressions in endometrial cancer.
    Kim J; Kim S; Lee HS; Yang W; Cho H; Chay DB; Cho SJ; Hong S; Kim JH
    Gynecol Oncol; 2018 May; 149(2):381-387. PubMed ID: 29572029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of PD-L1 expression with immunohistochemically determined molecular profile in endometrial carcinomas.
    Kir G; Soylemez T; Olgun ZC; Aydin A; McCluggage WG
    Virchows Arch; 2020 Dec; 477(6):845-856. PubMed ID: 32594230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of PD-L1 expression and CD8+ T cell infiltration in pulmonary neuroendocrine tumors.
    Wang H; Li Z; Dong B; Sun W; Yang X; Liu R; Zhou L; Huang X; Jia L; Lin D
    Diagn Pathol; 2018 May; 13(1):30. PubMed ID: 29789013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Programmed death ligand-1 and CD8 tumor-infiltrating lymphocytes (TILs) as prognostic predictors in ovarian high-grade serous carcinoma (HGSC).
    Farrag MS; Abdelwahab K; Farrag NS; Elrefaie WE; Emarah Z
    J Egypt Natl Canc Inst; 2021 Jul; 33(1):16. PubMed ID: 34241710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PD-L1 expression in basaloid squamous cell lung carcinoma: Relationship to PD-1
    Ilie M; Falk AT; Butori C; Chamorey E; Bonnetaud C; Long E; Lassalle S; Zahaf K; Vénissac N; Mouroux J; Cohen C; Brambilla E; Marquette CH; Hofman V; Hofman P
    Mod Pathol; 2016 Dec; 29(12):1552-1564. PubMed ID: 27562497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PD-L1 Expression in Endocervical Adenocarcinoma: Correlation With Patterns of Tumor Invasion, CD8+ Tumor-infiltrating Lymphocytes, and Clinical Outcomes.
    Rivera-Colon G; Chen H; Molberg K; Niu S; Strickland AL; Castrillon DH; Carrick K; Gwin K; Lea J; Zheng W; Lucas E
    Am J Surg Pathol; 2021 Jun; 45(6):742-752. PubMed ID: 33298732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased ERBB2 Gene Copy Numbers Reveal a Subset of Salivary Duct Carcinomas with High Densities of Tumor Infiltrating Lymphocytes and PD-L1 Expression.
    Chatzopoulos K; Collins AR; Sotiriou S; Keeney MG; Visscher DW; Rivera M; Schembri-Wismayer DJ; Lewis JE; Greipp PT; Sukov WR; Chintakuntlawar AV; Price KA; Garcia JJ
    Head Neck Pathol; 2020 Dec; 14(4):951-965. PubMed ID: 32350809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PD-L1 expression in carcinoma of the esophagogastric junction is positively correlated with T-cell infiltration and overall survival.
    Knief J; Lazar-Karsten P; Hummel R; Wellner U; Thorns C
    Pathol Res Pract; 2019 Jun; 215(6):152402. PubMed ID: 31043352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The PD-1, PD-L1 expression and CD3+ T cell infiltration in relation to outcome in advanced gastric signet-ring cell carcinoma, representing a potential biomarker for immunotherapy.
    Jin S; Xu B; Yu L; Fu Y; Wu H; Fan X; Wei J; Liu B
    Oncotarget; 2017 Jun; 8(24):38850-38862. PubMed ID: 28418918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PD-L1 expression and the immune microenvironment in primary invasive lobular carcinomas of the breast.
    Thompson ED; Taube JM; Asch-Kendrick RJ; Ogurtsova A; Xu H; Sharma R; Meeker A; Argani P; Emens LA; Cimino-Mathews A
    Mod Pathol; 2017 Nov; 30(11):1551-1560. PubMed ID: 28731046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastases.
    Kakavand H; Vilain RE; Wilmott JS; Burke H; Yearley JH; Thompson JF; Hersey P; Long GV; Scolyer RA
    Mod Pathol; 2015 Dec; 28(12):1535-44. PubMed ID: 26403784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Role of Tumoral PD-L1 and IDO1 Expression, and Intratumoral CD8+ and FoxP3+ Lymphocyte Infiltrates in 132 Primary Cutaneous Merkel Cell Carcinomas.
    Donizy P; Wu CL; Kopczynski J; Pieniazek M; Biecek P; Ryś J; Hoang MP
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of programmed cell death-ligand 1 expression and the immune microenvironment at the invasive front of colorectal cancers with high microsatellite instability.
    Korehisa S; Oki E; Iimori M; Nakaji Y; Shimokawa M; Saeki H; Okano S; Oda Y; Maehara Y
    Int J Cancer; 2018 Feb; 142(4):822-832. PubMed ID: 29044503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.